This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: The University of British Columbia. Active years: 2013-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2017
Title: The Innovations of Kai Hilpert
Introduction
Kai Hilpert is an accomplished inventor based in Vancouver, Canada. He has made significant contributions to the field of antimicrobial peptides, with a focus on their immunomodulatory properties. His work is recognized for its potential impact on healthcare and disease prevention.
Latest Patents
Hilpert holds 3 patents, with his latest inventions centered around small cationic antimicrobial peptides. These peptides are designed to enhance host defense mechanisms against pathogens, showcasing his commitment to advancing medical science.
Career Highlights
Kai Hilpert is affiliated with the University of British Columbia, where he conducts research and develops innovative solutions in the field of antimicrobial peptides. His academic background and research initiatives have positioned him as a leader in his area of expertise.
Collaborations
Hilpert collaborates with notable researchers, including Robert E W Hancock and Artem Cherkasov. These partnerships enhance the scope and impact of his research, fostering a collaborative environment for innovation.
Conclusion
Kai Hilpert's work in antimicrobial peptides exemplifies the intersection of innovation and healthcare. His contributions are paving the way for new therapeutic approaches to combat infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile